Published TCIMAIL newest issue No.199
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 130-95-0 | Product Number: Q0028
Quinine
×
![]()
×
Purity: >98.0%(T)
Synonyms:
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
Shipping Information
|
|---|---|---|---|---|---|
| 25G |
€56.00
|
12 | ≥80 |
|
|
| 100G |
€183.00
|
7 | 14 |
|
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | Q0028 |
Purity / Analysis Method 
|
>98.0%(T) |
| Molecular Formula / Molecular Weight | C__2__0H__2__4N__2O__2 = 324.42 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Hygroscopic |
| CAS RN | 130-95-0 |
| Reaxys Registry Number | 5293630 |
| PubChem Substance ID | 87575561 |
| SDBS (AIST Spectral DB) | 2170 |
| Merck Index (14) | 8061 |
| MDL Number | MFCD00198096 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 96.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 174.0 to 179.0 °C |
| Specific rotation [a]20/D | -160 to -170 deg(C=2, EtOH) |
| Solubility in Methanol | very faint turbidity |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 177 °C |
| Specific Rotation | -165° (C=2,EtOH) |
| Solubility in water | Insoluble |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. H317 : May cause an allergic skin reaction. H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| Precautionary Statements | P261 : Avoid breathing dust. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P284 : Wear respiratory protection. P342 + P311 : If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P304 + P340 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. |
Related Laws:
| EC Number | 205-003-2 |
| RTECS# | VA6020000 |
Transport Information:
| HS Number | 2939200000 |
Application
Efflux pump research
Quinine has been reported to inhibit efflux pump in methicillin-resistant Staphylococcus aureus (MRSA).1)
(The product is for research purpose only.)
(The product is for research purpose only.)
Reference
- 1) Inhibitory and Resistance-Modifying Potential of Plant-Based Alkaloids Against Methicillin-Resistant Staphylococcus aureus (MRSA)
- 1)Fatal Dose of Sulphate of Quinine
- 2)Antimalarial Drug Toxicity (a review)
- 3)Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications (a review)
- 4)Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria (a review)
Application
Quinine, an Antimalarial Substance
Quinine is one of the alkaloids which is included in the bark of cinchona tree and has been researched since 19th century.1) It has an anti-malarial activity2-4) and is considered to inhibit heme polymerase of plasmodium and to indicate toxicity to plasmodium. There are other antimalarial substances such as chloroquine diphosphate [C2301], hydroxychloroquine sulfate [H1306] and artemisinin [A2118]. (The product is for research purpose only)
References
Application
Asymmetric Tandem Michael Addition/Oxidation of Pyrazolones with p-Benzoquinone Using Cinchona Alkaloid Catalysts
Typical Procedure:
p-Benzoquinone (42.6 mg, 0.4 mmol) and quinine (1.3 mg, 2 mol%) are dissolved in 1,2-dichloroethane (2 mL). The solution is stirred at 25 °C for 10 min, after which a 4-substituted pyrazol-5-one (0.2 mmol) is added to the mixture. The solution is stirred at 25 °C for 24 h. Next, the solvent is removed under reduced pressure. The residue is directly subjected to column chromatography (petroleum ether/EtOAc = 10:1–6:1) to afford the desired product.
p-Benzoquinone (42.6 mg, 0.4 mmol) and quinine (1.3 mg, 2 mol%) are dissolved in 1,2-dichloroethane (2 mL). The solution is stirred at 25 °C for 10 min, after which a 4-substituted pyrazol-5-one (0.2 mmol) is added to the mixture. The solution is stirred at 25 °C for 24 h. Next, the solvent is removed under reduced pressure. The residue is directly subjected to column chromatography (petroleum ether/EtOAc = 10:1–6:1) to afford the desired product.
References
PubMed Literature
Documents
Product Articles
[Research Articles] Asymmetric Tandem Michael Addition/Oxidation of Pyrazolones with p-Benzoquinone Using Cinchona Alkaloid CatalystsProduct Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.